Page last updated: 2024-08-26

lysophosphatidic acid and Carcinoma, Hepatocellular

lysophosphatidic acid has been researched along with Carcinoma, Hepatocellular in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.26)18.2507
2000's4 (21.05)29.6817
2010's14 (73.68)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agosti, P; Gigante, I; Lopane, C; Mazzocca, A; SabbĂ , C1
Chen, X; Chen, YX; Ding, G; He, J; Jin, L; Li, X; Lou, L; Tao, X; Wu, S; Ye, W; Zhu, J1
Liu, XJ; Lv, LX; Wang, Q; Yang, P; Zhang, GD; Zhang, L; Zhao, M; Zhu, Y1
Ahrens, WA; Iannitti, DA; Mckillop, IH; Showlater, V; Sokolov, E; Swet, JH; Zuckerman, V1
Ahmad, NB; Baba, H; Bain, G; Baumert, TF; Beppu, T; Bian, CB; Chuang, WL; Chung, RT; Colombo, M; Dai, CY; El-Abtah, M; Erstad, DJ; Friedman, SL; Fuchs, BC; Ghoshal, S; Goossens, N; Gunasekaran, G; Higashi, T; Hoshida, H; Hoshida, Y; Iavarone, M; Kim, RS; Kobayashi, M; Koh, AP; Kumada, H; Lanuti, M; Lauwers, GY; Lee, Y; Llovet, JM; Mahajan, M; Nair, VD; Nakagawa, S; Sangiovanni, A; Schwarz, ME; Song, WM; Subramanian, A; Sun, X; Tager, AM; Tanabe, KK; Venkatesh, A; Villanueva, A; Wei, L; Yamada, S; Yu, ML; Zhang, B1
Hamano, F; Ishii, S; Kihara, Y; Masago, K; Nakanishi, H; Shimizu, T; Taguchi, R; Tajima, Y; Yanagida, K1
Maluccio, MA; Scott, RE; Skill, NJ; Wu, J1
Han, JW; Jeong, KJ; Kang, J; Kim, JM; Lee, HY; Lee, J; Lee, JS; Mills, GB; Panupinthu, N; Park, CG; Park, SY; Yu, S1
Fukushima, N; Hayashi, M; Honoki, K; Mori, T; Okabe, K; Teranishi, M; Tsujiuchi, T; Yamawaki, Y1
Antonaci, S; Dituri, F; Giannelli, G; Lupo, L; Mazzocca, A; Quaranta, M1
Deng, AM; Wu, SS; Xia, Q; Zheng, M1
Fan, F; Ma, YG; Shi, S; Yao, ZZ; Zhu, B1
Ikeda, H; Yatomi, Y1
Jianmin, W; Maluccio, MA; Skill, NJ; Tector, AJ; Yan, X; Zhao, Z1
Ahrens, WA; Eheim, AL; McKillop, IH; McMillan, MT; Simo, KA; Sindram, D; Sokolov, E; Swet, JH; Thompson, KJ; Walling, TL1
French, R; Nguyen, GH; Radhakrishna, H1
Horita, Y; Inoue, M; Mizuno, K; Mukai, M; Ohashi, K1
Akedo, H; Itoh, K; Matsumura, F; Yoshioka, K1
Akedo, H; Imamura, F; Iwasaki, T; Mukai, M; Nakamura, H; Tatsuta, M; Togawa, A1

Reviews

2 review(s) available for lysophosphatidic acid and Carcinoma, Hepatocellular

ArticleYear
Implications of the lysophosphatidic acid signaling axis in liver cancer.
    Biochimica et biophysica acta. Reviews on cancer, 2017, Volume: 1868, Issue:1

    Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Lysophospholipids; Phospholipids; Risk Factors; Signal Transduction

2017
Autotaxin in liver fibrosis.
    Clinica chimica acta; international journal of clinical chemistry, 2012, Nov-20, Volume: 413, Issue:23-24

    Topics: Carcinoma, Hepatocellular; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Lysophospholipids; Phosphoric Diester Hydrolases; Pruritus

2012

Other Studies

17 other study(ies) available for lysophosphatidic acid and Carcinoma, Hepatocellular

ArticleYear
Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor.
    The Journal of international medical research, 2013, Volume: 41, Issue:1

    Topics: Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Lysophospholipids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Receptors, Lysophosphatidic Acid

2013
Alkylglyceronephosphate synthase (AGPS) alters lipid signaling pathways and supports chemotherapy resistance of glioma and hepatic carcinoma cell lines.
    Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:7

    Topics: Alkyl and Aryl Transferases; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; beta Catenin; Carcinoma, Hepatocellular; Caspase 3; Caspase 8; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dinoprostone; Drug Resistance, Neoplasm; Glioma; Hep G2 Cells; Humans; Inhibitor of Apoptosis Proteins; Lipid Metabolism; Liver Neoplasms; Lysophospholipids; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Receptors, Lysophosphatidic Acid; RNA Interference; RNA, Small Interfering; Signal Transduction; Survivin

2014
Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells.
    Oncotarget, 2016, Jan-19, Volume: 7, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Hep G2 Cells; Humans; Liver Neoplasms; Lysophospholipids; Male; Middle Aged; Neoplastic Stem Cells; Receptors, Lysophosphatidic Acid; RNA Interference; RNA, Small Interfering; Signal Transduction

2016
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.
    Cancer cell, 2016, Dec-12, Volume: 30, Issue:6

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Profiling; Gene Regulatory Networks; Genetic Predisposition to Disease; Humans; Liver Cirrhosis; Liver Neoplasms; Lysophospholipids; Rats; Risk Factors; Signal Transduction; Xenograft Model Antitumor Assays

2016
Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6.
    The Journal of biological chemistry, 2009, Jun-26, Volume: 284, Issue:26

    Topics: Animals; Blotting, Western; Calcium; Carcinoma, Hepatocellular; Cell Membrane; Cells, Cultured; Cloning, Molecular; Cyclic AMP; Endothelium, Vascular; GTP-Binding Protein alpha Subunits, G12-G13; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Liver Neoplasms, Experimental; Lysophospholipids; Neuroblastoma; Radioligand Assay; Rats; Receptors, Purinergic P2; Umbilical Veins

2009
Hepatocellular carcinoma associated lipid metabolism reprogramming.
    The Journal of surgical research, 2011, Volume: 169, Issue:1

    Topics: Bile; Carcinoma, Hepatocellular; Case-Control Studies; Choline; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lipid Metabolism; Liver; Liver Neoplasms; Lysophosphatidylcholines; Lysophospholipids; Phospholipids; Receptors, G-Protein-Coupled

2011
Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression.
    Oncogene, 2011, Mar-17, Volume: 30, Issue:11

    Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Lysophospholipids; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Receptors, Lysophosphatidic Acid; Signal Transduction

2011
Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells.
    Molecular carcinogenesis, 2011, Volume: 50, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Methylation; Gene Expression Regulation, Neoplastic; Liver; Liver Neoplasms; Lung; Lung Neoplasms; Lysophospholipids; Mutation; Neoplasms; Rats; Receptors, Lysophosphatidic Acid

2011
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts.
    Hepatology (Baltimore, Md.), 2011, Sep-02, Volume: 54, Issue:3

    Topics: Actins; Carcinoma, Hepatocellular; Cell Differentiation; Disease Progression; Fibroblasts; Humans; Liver Neoplasms; Lysophospholipids; Myofibroblasts; Phosphoric Diester Hydrolases

2011
Cholera toxin inhibits human hepatocarcinoma cell proliferation in vitro via suppressing ATX/LPA axis.
    Acta pharmacologica Sinica, 2011, Volume: 32, Issue:8

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cholera Toxin; Humans; Liver Neoplasms; Lysophospholipids; Phosphoric Diester Hydrolases

2011
Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.
    Hepato-gastroenterology, 2012, Volume: 59, Issue:115

    Topics: Blotting, Western; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Humans; Liver Neoplasms; Lysophospholipids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction

2012
Lysophospholipid variants in hepatocellular carcinoma.
    The Journal of surgical research, 2013, Jun-15, Volume: 182, Issue:2

    Topics: Carcinoma, Hepatocellular; Fatty Liver; Hepatitis C; Humans; Liver Neoplasms; Liver Transplantation; Lysophospholipids; Mass Spectrometry; Non-alcoholic Fatty Liver Disease; Receptors, Lysophosphatidic Acid; RNA, Messenger; Tumor Necrosis Factor-alpha

2013
Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.
    The Journal of surgical research, 2013, Volume: 180, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Female; Humans; Liver Neoplasms; Lysophospholipids; Male; Middle Aged; Receptors, Lysophosphatidic Acid; RNA, Messenger

2013
Protein kinase A inhibits lysophosphatidic acid induction of serum response factor via alterations in the actin cytoskeleton.
    Cellular signalling, 2004, Volume: 16, Issue:10

    Topics: 1-Methyl-3-isobutylxanthine; Actin Cytoskeleton; Actins; Animals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Proliferation; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Cytoskeletal Proteins; Cytoskeleton; Female; Humans; Lysophospholipids; Ovarian Neoplasms; Paxillin; Phosphoproteins; Serum Response Factor; Tumor Cells, Cultured

2004
Suppression of the invasive capacity of rat ascites hepatoma cells by knockdown of Slingshot or LIM kinase.
    The Journal of biological chemistry, 2008, Mar-07, Volume: 283, Issue:10

    Topics: Actin Depolymerizing Factors; Actins; Animals; Ascites; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cytoskeleton; Destrin; Epithelium; Focal Adhesions; Lim Kinases; Lysophospholipids; Microfilament Proteins; Neoplasm Invasiveness; Neoplasm Proteins; Phosphoric Monoester Hydrolases; Phosphorylation; Rats; RNA, Small Interfering

2008
Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells.
    The Journal of biological chemistry, 1998, Feb-27, Volume: 273, Issue:9

    Topics: Actomyosin; ADP Ribose Transferases; Animals; Botulinum Toxins; Carcinoma, Hepatocellular; Epithelial Cells; GTP-Binding Proteins; Humans; Liver Neoplasms; Lysophospholipids; Mesentery; Models, Biological; Myosin Light Chains; Neoplasm Invasiveness; Phosphorylation; Rats; rhoA GTP-Binding Protein; Signal Transduction; Tumor Cells, Cultured

1998
Hepatoma cell migration through a mesothelial cell monolayer is inhibited by cyclic AMP-elevating agents via a Rho-dependent pathway.
    FEBS letters, 2000, Nov-03, Volume: 484, Issue:2

    Topics: Animals; Bucladesine; Carcinoma, Hepatocellular; Cell Movement; Cyclic AMP; Drug Interactions; Epithelium; Liver Neoplasms; Lysophospholipids; Neoplasms, Mesothelial; Rats; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Tumor Cells, Cultured

2000